Received: 15 October 2018
Accepted: 24 July 2019
First Online: 29 August 2019
Ethics approval and consent to participate
: As this was a service evaluation no specific ethics approval was required.
: AH - received financial support to attend international conferences from Bristol Myers Squibb.JL- nil to disclose.GC - nil to disclose.DI - Professor Isenberg has received honoraria from Merck Serono, Eli Lilly, XTLBio, Anthera, Celegene and UCB Pharma. These honoraria are passed onto a local arthritis charity.ML - Dr. Leandro has received honoraria for professional meeting participation from Roche UK, Roche Brazil, and Roche Portugal (less than $10,000 each), support for conference attendance from Roche and Chugai UK.